Tarja Ikonen

2.5k total citations
44 papers, 1.7k citations indexed

About

Tarja Ikonen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Tarja Ikonen has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Genetics. Recurrent topics in Tarja Ikonen's work include Prostate Cancer Treatment and Research (20 papers), Hormonal and reproductive studies (10 papers) and Genetic factors in colorectal cancer (8 papers). Tarja Ikonen is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Hormonal and reproductive studies (10 papers) and Genetic factors in colorectal cancer (8 papers). Tarja Ikonen collaborates with scholars based in Finland, United States and United Kingdom. Tarja Ikonen's co-authors include Olli A. Jänne, Jorma J. Palvimo, Pekka Kallio, Teuvo L.J. Tammela, Johanna Schleutker, Mika Matikainen, P. Reinikainen, Nina Mononen, Ville Autio and Pasi A. Koivisto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Tarja Ikonen

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarja Ikonen Finland 20 889 817 704 446 257 44 1.7k
Jos Veldscholte Netherlands 17 1.1k 1.2× 926 1.1× 1.3k 1.9× 797 1.8× 398 1.5× 20 2.3k
Johanna Schleutker Finland 28 1.3k 1.5× 1.0k 1.3× 944 1.3× 228 0.5× 511 2.0× 110 2.6k
Roberto E. Favoni Italy 20 844 0.9× 291 0.4× 356 0.5× 527 1.2× 327 1.3× 39 1.6k
Stephen N. Birrell Australia 18 481 0.5× 902 1.1× 551 0.8× 252 0.6× 591 2.3× 34 1.7k
C. Ris-Stalpers Netherlands 11 852 1.0× 719 0.9× 960 1.4× 759 1.7× 215 0.8× 11 1.6k
Christian Palmberg Finland 8 894 1.0× 556 0.7× 1.6k 2.3× 542 1.2× 550 2.1× 13 2.0k
John E. Monahan United States 12 918 1.0× 223 0.3× 561 0.8× 192 0.4× 306 1.2× 18 1.6k
Elizabeth Anderson United Kingdom 20 627 0.7× 1.1k 1.3× 277 0.4× 149 0.3× 527 2.1× 44 1.9k
Hisashi Hirakawa Japan 24 805 0.9× 741 0.9× 286 0.4× 138 0.3× 752 2.9× 63 2.0k

Countries citing papers authored by Tarja Ikonen

Since Specialization
Citations

This map shows the geographic impact of Tarja Ikonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Ikonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Ikonen more than expected).

Fields of papers citing papers by Tarja Ikonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Ikonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Ikonen. The network helps show where Tarja Ikonen may publish in the future.

Co-authorship network of co-authors of Tarja Ikonen

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Ikonen. A scholar is included among the top collaborators of Tarja Ikonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Ikonen. Tarja Ikonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antonarakis, Emmanuel S., Nicole Zhang, Jayati Saha, et al.. (2024). Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO Precision Oncology. 8(8). e2300330–e2300330. 5 indexed citations
2.
Fizazi, Karim, Gwénaëlle Gravis, Raffaele Ratta, et al.. (2024). 1605P Opevesostat (MK-5684/ODM-208), an oral CYP11A1 inhibitor, in metastatic castration-resistant prostate cancer (mCRPC): Updated CYPIDES phase II results. Annals of Oncology. 35. S968–S968. 1 indexed citations
3.
Fizazi, Karim, Guilhem Roubaud, Alice Bernard‐Tessier, et al.. (2024). MK-5684 (ODM-208), a CYP11A1 inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) with and without AR-LBD mutations: CYPIDES phase 2 results.. Journal of Clinical Oncology. 42(4_suppl). 159–159. 1 indexed citations
4.
Fizazi, Karim, Alice Bernard‐Tessier, Guilhem Roubaud, et al.. (2023). Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer. NEJM Evidence. 3(1). EVIDoa2300171–EVIDoa2300171. 13 indexed citations
5.
Fizazi, Karim, Alice Bernard‐Tessier, Philippe Barthélémy, et al.. (2022). 1364MO Preliminary phase II results of the CYPIDES study of ODM-208 in metastatic castration-resistant prostate (mCRPC) cancer patients. Annals of Oncology. 33. S1165–S1165. 2 indexed citations
6.
Bono, Petri, Christophe Massard, Katriina Peltola, et al.. (2020). Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours. ESMO Open. 5(6). e001081–e001081. 8 indexed citations
7.
Mukherjee, Subhendu, Chakshusmathi Ghadiyaram, Gerd Wohlfahrt, et al.. (2014). Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. Bioorganic & Medicinal Chemistry. 22(12). 3187–3203. 15 indexed citations
8.
Mattila, Henna, Martin Schindler, Jarkko Isotalo, et al.. (2011). NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene. BMC Cancer. 11(1). 327–327. 7 indexed citations
9.
Siltanen, Sanna, Kirsi Syrjäkoski, Rainer Fagerholm, et al.. (2008). ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer. European Journal of Human Genetics. 16(8). 983–991. 9 indexed citations
10.
Seppälä, Eija H., Ville Autio, Priya Duggal, et al.. (2006). KLF6 IVS1 -27G>A Variant and the Risk of Prostate Cancer in Finland. European Urology. 52(4). 1076–1081. 10 indexed citations
11.
Ikonen, Tarja, Ville Autio, Mika Matikainen, et al.. (2006). Identification of germline MLH1 alterations in familial prostate cancer. European Journal of Cancer. 42(16). 2802–2806. 26 indexed citations
12.
Syrjäkoski, Kirsi, Tarja Ikonen, Tuula Kuukasjärvi, et al.. (2005). Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. International Journal of Cancer. 118(2). 518–520. 19 indexed citations
13.
Seppälä, Eija H., Tarja Ikonen, Nina Mononen, et al.. (2003). CHEK2 variants associate with hereditary prostate cancer. British Journal of Cancer. 89(10). 1966–1970. 108 indexed citations
14.
Rökman, Annika, Tarja Ikonen, Eija H. Seppälä, et al.. (2002). Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate Cancer. The American Journal of Human Genetics. 70(5). 1299–1304. 174 indexed citations
15.
16.
17.
Ikonen, Tarja, Jorma J. Palvimo, & Olli A. Jänne. (1998). Heterodimerization is mainly responsible for the dominant negative activity of amino‐terminally truncated rat androgen receptor forms. FEBS Letters. 430(3). 393–396. 25 indexed citations
18.
Ikonen, Tarja, Jorma J. Palvimo, & Olli A. Jänne. (1997). Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators. Journal of Biological Chemistry. 272(47). 29821–29828. 308 indexed citations
19.
Palvimo, Jorma J., et al.. (1996). Mutual Transcriptional Interference between RelA and Androgen Receptor. Journal of Biological Chemistry. 271(39). 24151–24156. 190 indexed citations
20.
Palvimo, Jorma J., Pekka Kallio, Tarja Ikonen, Merja Mehto, & Olli A. Jänne. (1993). Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation.. Molecular Endocrinology. 7(11). 1399–1407. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jos Veldscholte Breakdown of academic impact, for papers by Johanna Schleutker Breakdown of academic impact, for papers by Roberto E. Favoni Breakdown of academic impact, for papers by Stephen N. Birrell Breakdown of academic impact, for papers by C. Ris-Stalpers Breakdown of academic impact, for papers by Christian Palmberg Breakdown of academic impact, for papers by John E. Monahan Breakdown of academic impact, for papers by Elizabeth Anderson Breakdown of academic impact, for papers by Hisashi Hirakawa
Rankless by CCL
2026